What does Impel Pharmaceuticals, Inc. do?

Jun 22 2025 06:31 PM IST
share
Share Via
Impel Pharmaceuticals, Inc. is a micro-cap pharmaceutical company with quarterly net sales of $5 million and a net loss of $14 million as of September 2023. It has a market cap of $0.36 million and does not pay dividends.
Overview:
Impel Pharmaceuticals, Inc. operates within the pharmaceuticals industry and is categorized as a micro-cap company. Financial Snapshot: - Net Sales: 5 Million (Quarterly Results - Sep 2023) - Net Profit: -14 Million (Quarterly Results - Sep 2023) - Market cap: USD 0.36 Million (Micro Cap) Key Metrics: - P/E: NA (Loss Making) - Industry P/E: NA - Dividend Yield: 0.00% - Debt Equity: -1.17 - Return on Equity: 68.81% - Price to Book: -0.00 Contact Details: Details: No Company Details Available Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Impel Pharmaceuticals, Inc.?
Jun 22 2025 05:53 PM IST
share
Share Via